IHC
Marker-first profiling
Cancer Diagnostics
The complete oncopathology stack, built for decisive cancer care
Phoenix Oncopathology partners with hospitals and clinicians through precise reporting, subspecialty interpretation, and efficient diagnostic workflows.
Trusted Across Cancer Care Workflows
Cancer CentersHospital Pathology TeamsOncology ClinicsTumor BoardsReferral DoctorsDiagnostic Networks
The whole diagnostic stack, on one platform.
From specimen intake to final sign-out, each diagnostic stage is quality-controlled for speed, clarity, and oncology-ready reporting.
Specimen Intake
Grossing Station
Microtomy
H&E Staining
IHC Marker Panel
Final Sign-Out
Specialized diagnostic modules
Every workflow is structured to reduce ambiguity and improve treatment confidence.
Core Service
Oncopathology
Subspecialty cancer tissue interpretation that supports confident oncology decisions.
ExploreCore Service
Histopathology
Microscopic tissue evaluation with standardized reporting for complex malignancies.
ExploreCore Service
Immunohistochemistry (IHC)
Marker-based tumor profiling for subtype classification and treatment planning.
ExploreCore Service
Cytopathology
Cell-based screening and diagnosis through FNAC and fluid cytology workflows.
ExploreCore Service
Second Opinion
Independent expert review for challenging and discordant diagnostic cases.
ExploreTests and Panels
Explore our available test services and click Know More to view a brief on each service page.
Test Service
BIOPSY SMALL
Histopathology assessment for small biopsy specimens with structured reporting.
Know MoreTest Service
Final Diagnosis Panel
Frozen diagnostic pathway support for urgent intraoperative or high-priority decisions.
Know MoreTest Service
Carcinoma Panel
Marker-driven panel support for carcinoma classification and treatment planning.
Know MoreTest Service
Lymphoma Panel
IHC panel workflow for lymphoma lineage and subtype refinement.
Know MoreTest Service
Sarcoma Panel
Panel-based support for soft tissue tumor characterization.
Know MoreTest Service
Renal Malignancy Panel
Focused marker panel for renal tumor pathology interpretation.
Know MoreTest Service
Germ Cell Tumor Panel
IHC-supported diagnostic panel for germ cell tumor evaluation.
Know MoreTest Service
Childhood tumors Panel
Pediatric tumor panel pathway for structured diagnostic support.
Know MoreTest Service
Melanoma Panel (max 5 markers)
Melanoma-oriented panel with up to five relevant markers.
Know MoreTest Service
BCPP
Breast Comprehensive Prognostic Panel focused on receptor and biomarker-driven breast oncology decisions.
Know MoreTest Service
Lineage Identification Panel (max 5 markers)
Targeted panel to identify tumor lineage using up to five markers.
Know MoreTest Service
Prognostic Markers
Marker testing intended to support prognostic interpretation in oncology.
Know MoreTest Service
ER PR HER2NEU
Breast marker panel including ER, PR, and HER2NEU.
Know MoreTest Service
ER PR
Dual receptor panel for estrogen and progesterone receptor status.
Know MoreTest Service
HER2
HER2 marker assessment as part of oncology biomarker workflows.
Know MoreTest Service
C-K it
Single-marker C-Kit assessment for selected tumor contexts.
Know MoreTest Service
Single Marker (Any)
Any individual marker test based on specific clinical requirement.
Know MoreTest Service
MMR
Mismatch repair marker assessment in appropriate oncology workflows.
Know MoreTest Service
PDL1 (SP263)
PDL1 SP263 assay support with standardized interpretive reporting.
Know MoreTest Service
BIOPSY MEDIUM
Histopathology evaluation for medium-complexity biopsy specimens.
Know MoreTest Service
BIOPSY LARGE (Resections)
Comprehensive pathology workflow for large resection specimens.
Know MoreTest Service
BIOPSY EXTRA LARGE ( UPTO 10 CONTAINERS)
Extra-large biopsy handling for specimen sets up to ten containers.
Know MoreTest Service
BIOPSY EXTRA LARGE (MORE THAN 10 CONTAINERS)
Extended workflow support for submissions exceeding ten containers.
Know MoreTest Service
EXPERT OPINION (Without IHC)
Expert pathology review based on morphology without IHC panel execution.
Know MoreRapid histopathology workflows
Streamlined specimen handling and microscopy protocols reduce delays in critical oncology pathways.
Know MoreAdvanced IHC marker panels
Marker-specific interpretation for tumor typing, prognosis cues, and treatment-direction support.
Know MoreCytopathology for early flags
FNAC and fluid cytology services built for faster triage and confident follow-up planning.
Know MoreSecond-opinion tumor review
Independent reassessment for discordant reports and high-stakes oncology decisions.
Know MoreOur Oncopathology Team
Experienced medical professionals focused on diagnostic precision.
Consultant Profile
Dr. Aparna Gangoli, MD
Lead Oncopathologist
- 26+ years of diagnostic excellence
- Subspecialty cancer pathology leadership
- Hospital-facing consultative reporting
Consultant Profile
Dr Gowri Prasanna MD FRCPath (UK)
Consultant Oncopathologist
- FRCPath (UK) credentialed diagnostic expertise in cancer pathology
- Advanced histopathology and clinicopathological correlation support
- Precise, treatment-focused reporting for oncology decision pathways
Consultant Profile
Dr. Hitankhi Padhi, MD
Consultant Oncopathologist
- Consultant oncopathology support for tissue-based cancer diagnosis
- Structured pathology communication for treatment planning
- Supports multidisciplinary tumor boards and referral teams
Consultant Profile
Dr. Anjali, MD
Consultant Oncopathologist
- Focused oncopathology interpretation for complex specimens
- Standardized reporting with clinicopathological correlation
- Collaborative support for hospital oncology workflows
Turnaround Snapshot
| Service | Typical TAT | Use Case |
|---|---|---|
| Histopathology | 24-72 hours | Biopsy and tissue diagnosis |
| IHC Panel | 2-5 days | Tumor typing and biomarkers |
| Cytopathology | 24-28 hours | FNAC and fluid cytology |
| Second Opinion | 2-6 days | Complex case review |